Chi‐Yi Chen

552 total citations
21 papers, 125 citations indexed

About

Chi‐Yi Chen is a scholar working on Hepatology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chi‐Yi Chen has authored 21 papers receiving a total of 125 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hepatology, 11 papers in Epidemiology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chi‐Yi Chen's work include Liver Disease Diagnosis and Treatment (11 papers), Hepatitis C virus research (11 papers) and Hepatitis B Virus Studies (9 papers). Chi‐Yi Chen is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Hepatitis C virus research (11 papers) and Hepatitis B Virus Studies (9 papers). Chi‐Yi Chen collaborates with scholars based in Taiwan, United States and Hong Kong. Chi‐Yi Chen's co-authors include Shi‐Ping Luh, Cheng‐Yuan Peng, Jia‐Horng Kao, Pin‐Nan Cheng, Tsai‐Yuan Hsieh, Ming‐Lung Yu, Chen‐Hua Liu, Chih‐Lin Lin, Kuo‐Chih Tseng and Eduardo E. Arriaga and has published in prestigious journals such as Alimentary Pharmacology & Therapeutics, Journal of Medical Virology and Journal of Gastroenterology and Hepatology.

In The Last Decade

Chi‐Yi Chen

17 papers receiving 122 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chi‐Yi Chen Taiwan 7 97 83 30 17 14 21 125
Mohsen Salama Egypt 7 101 1.0× 112 1.3× 22 0.7× 8 0.5× 8 0.6× 23 180
Dustin Bastaich United States 6 58 0.6× 59 0.7× 25 0.8× 10 0.6× 18 1.3× 13 98
Judit Vidal‐González Spain 6 93 1.0× 95 1.1× 15 0.5× 8 0.5× 24 1.7× 8 159
Sweta Chekuri United States 5 58 0.6× 76 0.9× 19 0.6× 13 0.8× 9 0.6× 7 104
Antonio Izzi Italy 7 79 0.8× 98 1.2× 63 2.1× 17 1.0× 23 1.6× 23 195
Yoann Barthe France 5 76 0.8× 82 1.0× 15 0.5× 4 0.2× 7 0.5× 6 133
Manuela Curescu Romania 9 259 2.7× 263 3.2× 29 1.0× 8 0.5× 9 0.6× 24 294
N.M. Castellaneta Italy 5 122 1.3× 106 1.3× 11 0.4× 18 1.1× 11 0.8× 13 158
Mary Afihene Ghana 6 72 0.7× 86 1.0× 19 0.6× 19 1.1× 29 2.1× 15 149
G Felten Germany 7 258 2.7× 277 3.3× 27 0.9× 17 1.0× 12 0.9× 13 310

Countries citing papers authored by Chi‐Yi Chen

Since Specialization
Citations

This map shows the geographic impact of Chi‐Yi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Yi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Yi Chen more than expected).

Fields of papers citing papers by Chi‐Yi Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi‐Yi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Yi Chen. The network helps show where Chi‐Yi Chen may publish in the future.

Co-authorship network of co-authors of Chi‐Yi Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Chi‐Yi Chen. A scholar is included among the top collaborators of Chi‐Yi Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi‐Yi Chen. Chi‐Yi Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tseng, Cheng‐Hao, Teng‐Yu Lee, Chi‐Yi Chen, et al.. (2025). Incidences of Virological and Clinical Relapses After Cessation of Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, or Entecavir in Patients With HBeAg‐Negative Chronic Hepatitis B. Journal of Gastroenterology and Hepatology. 40(5). 1245–1254.
2.
3.
Chang, Yu‐Ping, Ji‐Yuh Lee, Chi‐Yi Chen, et al.. (2025). Risk of Incident Type 2 Diabetes and Prediabetes in Patients With Direct Acting Antiviral‐Induced Cure of Hepatitis C Virus Infection. Alimentary Pharmacology & Therapeutics. 61(9). 1508–1518. 1 indexed citations
4.
5.
Fung, Scott, Calvin Q. Pan, Grace Lai–Hung Wong, et al.. (2023). Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks. Alimentary Pharmacology & Therapeutics. 59(2). 217–229. 7 indexed citations
6.
Lin, Chih‐Lin, Chi‐Ming Tai, Jee‐Fu Huang, et al.. (2022). The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan. Journal of Gastroenterology and Hepatology. 37(10). 1901–1910. 5 indexed citations
7.
Chen, Chi‐Yi, et al.. (2021). Infected liver cysts resulting from ascending cholangitis and cancer of the ampulla of Vater: A case report. Advances in digestive medicine. 9(2). 131–134. 1 indexed citations
8.
Chou, Chu‐Kuang, et al.. (2020). Management of gastrointestinal subepithelial tumors with endoscopic resection. Advances in digestive medicine. 9(1). 23–30.
9.
Tseng, Chih‐Wei, et al.. (2020). Characteristics of regulatory T‐cell function in patients with chronic hepatitis B and C coinfection. Journal of Viral Hepatitis. 27(8). 800–809. 6 indexed citations
10.
Liu, Chen‐Hua, Yu‐Lueng Shih, Sheng‐Shun Yang, et al.. (2019). Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non‐cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis. Journal of Gastroenterology and Hepatology. 34(11). 1977–1983. 7 indexed citations
11.
Kao, Jia‐Horng, Ming‐Lung Yu, Chi‐Yi Chen, et al.. (2018). Twelve‐week ravidasvir plus ritonavir‐boosted danoprevir and ribavirin for non‐cirrhotic HCV genotype 1 patients: A phase 2 study. Journal of Gastroenterology and Hepatology. 33(8). 1507–1510. 10 indexed citations
12.
Liu, Chen‐Hua, Ming‐Lung Yu, Cheng‐Yuan Peng, et al.. (2018). Comorbidities, concomitant medications and potential drug‐drug interactions with interferon‐free direct‐acting antiviral agents in hepatitis C patients in Taiwan. Alimentary Pharmacology & Therapeutics. 48(11-12). 1290–1300. 34 indexed citations
13.
Chien, Rong‐Nan, Cheng‐Yuan Peng, Jia‐Horng Kao, et al.. (2013). Higher adherence with 3‐year entecavir treatment than lamivudine or telbivudine in treatment‐naïve Taiwanese patients with chronic hepatitis B. Journal of Gastroenterology and Hepatology. 29(1). 185–192. 9 indexed citations
14.
Yan, Yuan‐Horng, et al.. (2011). Role of endoscopic sonography in the diagnosis of a fish bone perforation of the gastric wall resulting in a submucosal pseudotumor. Journal of Clinical Ultrasound. 39(7). 415–417. 2 indexed citations
15.
Luh, Shi‐Ping & Chi‐Yi Chen. (2009). Video-assisted thoracoscopic surgery (VATS) for the treatment of hepatic hydrothorax: report of twelve cases. Journal of Zhejiang University SCIENCE B. 10(7). 547–551. 20 indexed citations
16.
17.
Wu, I‐Chin, Nan‐Haw Chow, Pin‐Nan Cheng, et al.. (2007). Characterization of viral kinetics in patients with hepatitis B e antigen‐positive chronic hepatitis B. Journal of Medical Virology. 79(6). 663–669. 5 indexed citations
18.
Shen, You-Gen, Changjun Gao, & Chi‐Yi Chen. (2003). Quantum Statistical Entropy of Six Dimensional Horowitz-Strominger Black Holes. General Relativity and Gravitation. 35(4). 619–630.
19.
Chen, Chi‐Yi, et al.. (1978). Desarrollo regional-urbano y ordenamiento del territorio : mito y realidad. Medical Entomology and Zoology. 2 indexed citations
20.
Arriaga, Eduardo E. & Chi‐Yi Chen. (1968). Movimientos Migratorios en Venezuela.. Population Studies. 22(3). 417–417. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohsen Salama Breakdown of academic impact, for papers by Dustin Bastaich Breakdown of academic impact, for papers by Judit Vidal‐González Breakdown of academic impact, for papers by Sweta Chekuri Breakdown of academic impact, for papers by Antonio Izzi Breakdown of academic impact, for papers by Yoann Barthe Breakdown of academic impact, for papers by Manuela Curescu Breakdown of academic impact, for papers by N.M. Castellaneta Breakdown of academic impact, for papers by Mary Afihene Breakdown of academic impact, for papers by G Felten
Rankless by CCL
2026